<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive Evaluation Option License: Pre-clinical Evaluation of Human Therapeutics Utilizing Ubiquitin Based Fusion Proteins With Apoptosis Modifying Proteins Such as BCL-XL</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive Evaluation Option License: Pre-clinical Evaluation of Human Therapeutics Utilizing Ubiquitin Based Fusion Proteins With Apoptosis Modifying Proteins Such as BCL-XL</h1>
    <p class="timestamp">Published: 2012-10-30 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive evaluation option license to practice the inventions covered under the scope of United States Patent No. 6,737,511 issued May 18, 2004 entitled "Receptor-mediated Uptake of an Extracellular BCL- x<INF>L</INF> Fusion Protein Inhibits Apoptosis" (HHS Ref. No. E-073- 1999/0-US-02; Inventors Richa...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2012-26601</p>
    <p><strong>Publication Date:</strong> 2012-10-30</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/10/30/2012-26601/prospective-grant-of-exclusive-evaluation-option-license-pre-clinical-evaluation-of-human">https://www.federalregister.gov/documents/2012/10/30/2012-26601/prospective-grant-of-exclusive-evaluation-option-license-pre-clinical-evaluation-of-human</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-26601</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
